New stock news | New Element Pharmaceuticals submits application to Hong Kong Stock Exchange. The company currently has no products approved for commercial sale.

According to the financial news app Zhitong Finance, as disclosed by the Hong Kong Stock Exchange on September 15th, Hangzhou New Element Pharmaceutical Co., Ltd. (referred to as New Element Pharmaceutical) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CITIC Securities as its exclusive sponsor.